|
CCNB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.237620E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.47830000000327E-05 |
| Normal-vs-Stage2 |
1.102090E-02 |
| Normal-vs-Stage3 |
7.504900E-03 |
| Normal-vs-Stage4 |
1.598180E-03 |
| Stage1-vs-Stage2 |
9.964600E-01 |
| Stage1-vs-Stage3 |
8.976000E-01 |
| Stage1-vs-Stage4 |
5.019400E-01 |
| Stage2-vs-Stage3 |
9.314800E-01 |
| Stage2-vs-Stage4 |
6.501600E-01 |
| Stage3-vs-Stage4 |
5.399400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.099400E-03 |
| Normal-vs-AfricanAmerican |
1.578830E-03 |
| Normal-vs-Asian |
4.629000E-04 |
| Caucasian-vs-AfricanAmerican |
1.600410E-01 |
| Caucasian-vs-Asian |
1.592190E-01 |
| AfricanAmerican-vs-Asian |
5.150400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.094330E-02 |
| Normal-vs-Female |
2.26869999999657E-05 |
| Male-vs-Female |
4.052800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.536100E-03 |
| Normal-vs-Age(41-60Yrs) |
4.2132000000028E-05 |
| Normal-vs-Age(61-80Yrs) |
3.441500E-03 |
| Normal-vs-Age(81-100Yrs) |
6.182400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.475900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.499000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.230200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.567400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.466000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.064200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.876400E-01 |
| Classical-VS-Follicular |
1.798240E-01 |
| Classical-VS-Other |
9.095400E-01 |
| Classical-VS-Normal |
8.350200E-04 |
| Tall-VS-Follicular |
6.721200E-01 |
| Tall-VS-Other |
7.630600E-01 |
| Tall-VS-Normal |
1.301620E-02 |
| Follicular-VS-Other |
5.975800E-01 |
| Follicular-VS-Normal |
3.182500E-04 |
| Other-VS-Normal |
2.660200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.940570E-03 |
| Normal-vs-N1 |
1.67220000002466E-06 |
| N0-vs-N1 |
9.643800E-03 |
|
|
